Back
Maze Therapeutics 10K Form
Buy
62
MAZE
Maze Therapeutics
Last Price:
$14.86
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MAZE News And Ratings
See the #1 stock for the next 7 days that we like better than MAZE
MAZE Financial Statistics
Sales & Book Value
| Annual Sales: | $167.5M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 8.77 |
| Annual Sales: | $0.00 |
| Price / Book: | 2.21 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Maze Therapeutics Earnings Forecast
Key Maze Therapeutics Financial Ratios
-
The Research & Development expenses have been 49.85% of Revenue.
-
The Net Earning history of MAZE is 31.18% of Total Revenues.
-
Per Share Earnings over the last 3 years have been positive in 2 years.
Maze Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Current Symbol: | MAZE |
| Website: | mazetx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 193.62 |
|---|---|
| Forward P/E Ratio: | 0 |
MAZE Technical Analysis vs Fundamental Analysis
Buy
62
Maze Therapeutics (MAZE)
is a Buy
Is Maze Therapeutics a Buy or a Sell?
-
Maze Therapeutics stock is rated a BuyThe current Maze Therapeutics [MAZE] share price is $15.06. The Score for MAZE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.